Continuing metformin throughout the first trimester in women with polycystic ovary syndrome shows potential to reduce miscarriage risk and increase clinical pregnancy rates.
Continuing metformin throughout the first trimester in women with polycystic ovary syndrome showed the potential to reduce miscarriage risk and increase clinical pregnancy rates compared with placebo.
A meta-analysis of 12 randomized controlled trials involving 1708 women suggested that stopping metformin at pregnancy confirmation might be less beneficial than continuation through the first trimester.Researchers conducted a systematic review and meta-analysis of randomized controlled trials evaluating metformin started preconception and continued at least until positive pregnancy test compared with placebo or no treatment in women with PCOS. The analysis included 12 trustworthy studies with 1708 participants, with trials conducted across 14 countries spanning five continents, all graded as low to moderate quality evidence. The primary outcome measure focused on miscarriage rate, defined as pregnancy loss prior to 20 completed weeks of gestation, while secondary outcomes included clinical pregnancy and live birth rates. Investigators performed indirect comparisons between treatment groups using the Bucher technique to evaluate clinical pregnancy, miscarriage, and live birth rates for metformin treatment continued throughout first trimester vs stopped at a positive pregnancy test.Women receiving preconception metformin continued throughout the first trimester had higher clinical pregnancy rates , potential reduction in miscarriage , and possible increase in live birth compared with placebo or no treatment. Participants who stopped metformin once pregnant showed an increased clinical pregnancy rate but also had a higher miscarriage risk compared with placebo or no treatment. Indirect comparisons consistently favored continuing metformin through first trimester vs stopping at pregnancy confirmation for clinical pregnancy , miscarriage , and live birth .“Women with PCOS have been shown to have a fivefold increased risk per year of developing insulin resistance and subsequent type 2 diabetes. Insulin resistance has been shown to be independently associated with a higher risk of miscarriage. Metformin acts by decreasing gluconeogenesis, lipogenesis and enhancing glucose uptake, all of which in turn reduce insulin resistance,” wrote the authors of the study.The study was led by James Cheshire, PhD, Birmingham Women’s and Children’s NHS Foundation Trust in Birmingham, England. It wasAccording to the authors, the main limitation was the inherent heterogeneous nature of the study population and the overall low quality of evidence. Women with PCOS have different phenotypes and varying degrees of hyperandrogenism and insulin resistance, which could not be accounted for in the analyses. Additionally, many studies did not subdivide pregnancy outcome data by body mass index , preventing meaningful analyses in BMI subgroups. The limited outcome data in spontaneously conceiving populations make it difficult to extrapolate findings to this group.The authors reported having no conflicts of interest. The study received no external funding. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.
Pregnant Spontaneous Abortion Miscarriage Polycystic Ovary Syndrome Polycystic Ovarian Disease Polycystic Ovarian Syndrome PCOS Stein-Leventhal Syndrome Ovaries Female Infertility Birth Insulin Resistance Body Mass Index BMI Meta-Analysis Preconception Preconception Care Preconception Counseling Pre-Conception Preconception Counselling Diabetes Mellitus Type 2
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Metformin being studied as colon cancer-stopping supplementBusiness Insider tells the global tech, finance, stock market, media, economy, lifestyle, real estate, AI and innovative stories you want to know.
Read more »
Doctors Say Metformin Could Help Prevent Colon CancerDana Schulz is an experienced editor, writer, and content strategist who is just as likely to be crunching the latest housing market data as she is to be sharing all the best new kitchen gadgets at Target. She has written about real estate, apartment living, home decor, and history for more than 14 years.
Read more »
Raiders' first-rounder Ashton Jeanty practices for first time at rookie campAshton Jeanty practiced for the first time with the Raiders at rookie camp, and expectations are high for the first-round draft pick.
Read more »
The First Fantastic Four: First Steps Lego Set Heralds the Coming of Brick-Built GalactusGuest starring some very distressing Lego Mr. Fantastic legs.
Read more »
New ‘Fantastic Four: First Steps’ LEGO Set Unveils First Look at World-Eating GalactusA new Fantastic Four: First Steps LEGO set gives us a sneak peek at Galactus. Check it out now.
Read more »
You Can Soon Watch Sylvester Stallone’s First Starring Role For the First Time in DecadesSylvester Stallone as union worker Johnny Kovak protesting with his colleagues in F.I.S.T.
Read more »